Podocyturia as a Diagnostic Marker for Preeclampsia amongst High-Risk Pregnant Patients

Abstract EN

Urinary podocyte (podocyturia) has been studied as a diagnostic marker for preeclampsia.

We sought to validate its use in preeclampsia and in differentiating it from other high risk pregnancy states.

We studied an obstetric population at high risk to develop preeclampsia (study group) and uncomplicated pregnancies (control group) by analyzing their urine sediment for podocytes within 24 hours of delivery.

Podocytes were identified by immunohistochemistry using the podocyte-specific protein synaptopodin.

Of the 56 patients who were enrolled, 29 patients were diagnosed with preeclampsia, 9 patients had hypertensive conditions such as chronic and gestational hypertension, 6 patients had Type I/II and gestational diabetes mellitus, 3 patients were classified as others, and 9 patients exhibited uncomplicated pregnancies.

Podocyturia was identified in 11 out of 29 (38%) of patients with preeclampsia/eclampsia, 3 out of 9 (33%) with gestational and chronic hypertension, and 3 out of 6 (50%) with Type I/II and gestational diabetes mellitus.

None of the 9 patients (0%) with uncomplicated pregnancies demonstrated podocyturia.

The sensitivity and specificity of podocyturia for preeclampsia were found to be 38% and 70%.

Our study showed that podocyturia does not appear to be a sensitive nor a specific marker to diagnose preeclampsia.